Cargando…
Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient
Huntington's disease (HD) is a genetic, degenerative, and progressive central nervous system disease. It is characterized by motor abnormalities and cognitive and psychiatric symptoms. Objective. To describe the precise degree of clinical severity of patients with HD through a new neurocognitiv...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235665/ https://www.ncbi.nlm.nih.gov/pubmed/22203851 http://dx.doi.org/10.1155/2011/385894 |
_version_ | 1782218625319436288 |
---|---|
author | King, Anna Lucia Spear Valença, Alexandre Martins e Silva, Adriana Cardoso de Oliveira Cerqueira, Ana Claudia Ferraz, Lígia Maria Chaves Nardi, Antonio Egidio |
author_facet | King, Anna Lucia Spear Valença, Alexandre Martins e Silva, Adriana Cardoso de Oliveira Cerqueira, Ana Claudia Ferraz, Lígia Maria Chaves Nardi, Antonio Egidio |
author_sort | King, Anna Lucia Spear |
collection | PubMed |
description | Huntington's disease (HD) is a genetic, degenerative, and progressive central nervous system disease. It is characterized by motor abnormalities and cognitive and psychiatric symptoms. Objective. To describe the precise degree of clinical severity of patients with HD through a new neurocognitive assessment. Methods. Unprecedented battery of computerized tests, CNSVS (Central Nervous System Vital Signs), was applied at three different moments in 2008, 2009, and 2010. The accurate and reliable CNSVS objectively provided the cognitive state of patients and allowed for the evaluation of disease progression. Case Report. P., 26, female, without any medication, with normal psychomotor development is a parent carrier of HD. In 2008, she was diagnosed with HD in accordance with the Medical Genetics Laboratories. Conclusion. The tests may be useful to reveal the exact measure of the current evolutionary stage of HD patients, allowing for more efficient planning of treatment and future procedures, such as the medication, therapy, and physical activity to be administered. |
format | Online Article Text |
id | pubmed-3235665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-32356652011-12-27 Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient King, Anna Lucia Spear Valença, Alexandre Martins e Silva, Adriana Cardoso de Oliveira Cerqueira, Ana Claudia Ferraz, Lígia Maria Chaves Nardi, Antonio Egidio Case Rep Med Case Report Huntington's disease (HD) is a genetic, degenerative, and progressive central nervous system disease. It is characterized by motor abnormalities and cognitive and psychiatric symptoms. Objective. To describe the precise degree of clinical severity of patients with HD through a new neurocognitive assessment. Methods. Unprecedented battery of computerized tests, CNSVS (Central Nervous System Vital Signs), was applied at three different moments in 2008, 2009, and 2010. The accurate and reliable CNSVS objectively provided the cognitive state of patients and allowed for the evaluation of disease progression. Case Report. P., 26, female, without any medication, with normal psychomotor development is a parent carrier of HD. In 2008, she was diagnosed with HD in accordance with the Medical Genetics Laboratories. Conclusion. The tests may be useful to reveal the exact measure of the current evolutionary stage of HD patients, allowing for more efficient planning of treatment and future procedures, such as the medication, therapy, and physical activity to be administered. Hindawi Publishing Corporation 2011 2011-12-04 /pmc/articles/PMC3235665/ /pubmed/22203851 http://dx.doi.org/10.1155/2011/385894 Text en Copyright © 2011 Anna Lucia Spear King et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report King, Anna Lucia Spear Valença, Alexandre Martins e Silva, Adriana Cardoso de Oliveira Cerqueira, Ana Claudia Ferraz, Lígia Maria Chaves Nardi, Antonio Egidio Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient |
title | Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient |
title_full | Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient |
title_fullStr | Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient |
title_full_unstemmed | Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient |
title_short | Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient |
title_sort | huntington's disease: two-year observational follow-up of executive function evaluation with cns vital signs test in an adult patient |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235665/ https://www.ncbi.nlm.nih.gov/pubmed/22203851 http://dx.doi.org/10.1155/2011/385894 |
work_keys_str_mv | AT kingannaluciaspear huntingtonsdiseasetwoyearobservationalfollowupofexecutivefunctionevaluationwithcnsvitalsignstestinanadultpatient AT valencaalexandremartins huntingtonsdiseasetwoyearobservationalfollowupofexecutivefunctionevaluationwithcnsvitalsignstestinanadultpatient AT esilvaadrianacardosodeoliveira huntingtonsdiseasetwoyearobservationalfollowupofexecutivefunctionevaluationwithcnsvitalsignstestinanadultpatient AT cerqueiraanaclaudia huntingtonsdiseasetwoyearobservationalfollowupofexecutivefunctionevaluationwithcnsvitalsignstestinanadultpatient AT ferrazligiamariachaves huntingtonsdiseasetwoyearobservationalfollowupofexecutivefunctionevaluationwithcnsvitalsignstestinanadultpatient AT nardiantonioegidio huntingtonsdiseasetwoyearobservationalfollowupofexecutivefunctionevaluationwithcnsvitalsignstestinanadultpatient |